Comparative effect of streptokinase and alteplase on electrocardiogram and angiogram signs of myocardial reperfusion in st segment elevation acute myocardial infarction

Srpski Arhiv za Celokupno Lekarstvo

Volumn 136, Issue 9-10, 2008, Pages 481-487

  Tomašević, Miloje ^a   Kostić, Tomislav ^a   Apostolović, Svetlana ^a   Perišić, Zoran ^a   Djordjevic Radojkovic, Danijela ^a   Koraćević, Goran ^a   Šalinger Martinović, Sonja ^a  

^a Clinical Centre Nis   (Serbia)

Author keywords

Fibrinolysis; Myocardial reperfusion; St segment elevation acute myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADULT; AGED; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 58849157715     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH0810481T     Document Type: Article

References (22)

1. Vasiljević Z, Mickovski-Katalina N, Panić G, et al. Klinička obeležja, lečenje i smrtnost bolesnika s akutnim koronarnim sindromom uSrbiji od 2002. do 2005. godine: analiza podataka Nacionalnog registraza akutni koronarni sindrom. Srp Arh Celok Lek 2007; 135(11-12): 645-54.
2. The GUSTO Investigators. An international randomized trial comparingfour thrombolytic strategies for acute myocardial infarction.N Engl J Med 1993; 329:673-82.
3. Assessment of the Safety and Efficacy of a New Thrombolytic(ASSENT-2) Investigators. Single-bolus tenecteplase compared withfront-loaded alteplase in acute myocardial infarction: the ASSENT-2double-blind randomised trial. Lancet 1999; 354:716-22.
4. The global use of strategies to open occluded coronary arteries (GUSTOIII) investigators. A comparison of reteplase with alteplase for the acutemyocardial infarction. N Engl J Med 1997; 337:1118-23.
5. Sleight P. Streptokinase is still the agent of choice for most patients with myocardial infarction. Am J Therapeut 1995; 2:128-35.
6. Simoons ML, Krzeminska-Pakula M, Alonso A, et al. For the AMI-SK investigators. Eur Heart J 2002; 23:1282-90.
7. Sabatine M, Cannon CP, Gibson CM, et al For the CLARITY-TIMI28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352:1179-89.
8. Dobrić M, Ostojić M, Nedeljković M, et al. Treatment of acute ST elevation myocardial infarction with primary percutaneous coronary intervention in Department of Cardiology, Clinical Centre of Serbia, Belgrade: movement and treatment of patients from the on set of chest pain till the attempt of reopening the infarct-reletedartery. Srp Arh Celok Lek 2007; 135(9-10):521-31.
9. Giraldez RR, Nicolau JC, Corbalan R, et al. Enoxaparin is superiorto un fractionated heparin in patients with ST elevation myocardialinfarction undergoing fibrinolysis regardless of the choice of lytic:an ExTRACT-TIMI 25 analysis. Eur Heart J 2007; 28:1566-73.
10. Antman EM, Morrow DA, McCabe CH, et al., For the ExTRACTTIMI25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006; 354:1477-88.
11. White HD, Braunwald E, Murphy SA, et al. Enoxaparin vs. unfractionatedheparin with fibrinolysis for ST-elevation myocardialinfarction in elderly and younger patients: results from ExTRACTTIMI25. Eur Heart J 2007; 28:1066-71.
12. Schroder R, Wegscheider K, Schroder K, et al., For the INJECT Trial Group. Extent of early ST segment elevation resolution: a strongpredictor of outcome in patients with acute myocardial infarctionand a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol 1995; 26:1657-64.
13. Schroder K, Wegscheider K, Zeymer U, et al. Extent of ST segment deviation in a single electrocardiogram lead 90 min after thrombolysisas a predictor of medium-term mortality in acute myocardial infarction. Lancet 2001; 358:1479-86.
14. Klootwijk P. Evaluation of reperfusion in the treatment of acutemyocardial infarction. In: Verheught FWA, editor. CoronaryReperfusion Therapy in Clinical Practice. London and New York:Taylor & Francis; 2006. p.129-147.
15. Shroeder R, Dissmann R, Bruggemann T, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994; 24:384-91.
16. Steg PG, Francois L, Lung B, et al. Long-term clinical outcomes afterrescue angioplasty are not different from those of successful thrombolysis for acute myocardial infarction. Eur Heart J 2005; 26:1831-7.
17. Armstrong PW, Wagner G, Goodman SG, et al., for the ASSENT3 Investigators. ST segment resolution in ASSENT 3: insights intothe role of three different treatment strategies for acute myocardial infarction. Eur Heart J 2003; 24:1515-22.
18. Zeymer U, Schroeder R, Tebbe U, et al. Non invasive detection ofearly infarct vessel patency by resolution of ST segment elevation inpatients with thrombolysis for acute myocardial infarction. Results ofthe angiographic substudy HIT-4 trial. Eur Heart J 2001; 22:769-75.
19. Kleiman NS, White HD, Ohman EM, et al., For the GUSTO Investigators. Mortality within 24 hours of thrombolysis for myocardialinfarction The importance of early reperfusion. Circulation 1994;90:2658-65.
20. The GUSTO Angiographic Investigators. The effects of tissueplasminogen activator, streptokinase, or both on coronary-arterypatency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-22.
21. Lablanche JM, Gueret P, Blanchard D, et al. Beneficial effects of very early PTCA in patients treated with intravenous thrombolysis for acute myocardial infarction: data from a nation-wide registry in France. Circulation 2002; 106(2):630(abstract).
22. McClelland AJJ, Owens CG, Walsh SJ, et al. Percutaneous coronary intervention and 1 year survival in patients treated with fibrinolytic therapy for acute ST-elevation myocardial infarction. Eur Heart J 2005; 26:544-8.